All treatments
Treatment
larotrectinib(Vitrakvi, BAY2757556) clinical trials
2 indexed studies · 1 currently recruiting
- Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
This study looks at how well a drug called VITRAKVI works and how safe it is for people with TRK fusion cancer. This type of cancer happens when certain genes fuse together. Doctors want to see how VITRAKVI helps patients in real-world use.
For: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States · Argentina · Australia - Active not recruitingPHASE1, PHASE2
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
This study is testing a new cancer medicine called larotrectinib for children with certain types of tumours. It looks at how safe the drug is, how it works in the body, and how well it helps treat cancers that have a specific gene change (NTRK fusion).
For: Solid Tumors Harboring NTRK FusionUnited States · Australia · Canada